Targeting and therapy of human glioma xenografts in vivo utilizing radiolabeled antibodies
β Scribed by Jeffery A. Williams; James A. Edwards; Jerry L. Klein; Larry E. Dillehay; Moody D. Wharam; Barry W. Wessels; Stanley E. Order
- Publisher
- Elsevier Science
- Year
- 1989
- Tongue
- English
- Weight
- 159 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Monoclonal antibody UJ13A radiolabelled with isotopes of iodine has been shown to selectively localize to human neuroblastoma xenografts. When ^131^IβUJ13A conjugates were given to nude mice at high doses (100β150 ΞΌCi), tumours temporarily disappeared, only to regrow. No selection for n
Radioimmunotherapy in humans is limited by toxicity to normal tissues, caused by circulating radio-antibody. Second antibody directed against the first (anti-tumor) antibody accelerates clearance of first antibody from normal tissues, and may thus improve the therapeutic ratio. The effect of second
The rate of catabolism of a radiolabelled monoclonal anti-CEA antibody has been compared with that of control IgG1 in control nude mice and in mice with CEA producing xenografts and antigen negative xenografts. The rate of catabolism of antibody, but not of IgG, was increased 3-4 fold in mice with x
## Abstract Our previous studies demonstrated that the oral antifungal agent ketoconazole (KT) induces apoptosis and G0/G1 phase cell cycle arrest in human cancer cell lines. In this study, we first demonstrated that KT (1 ΞΌM) potentiated the apoptotic effects of nocodazole (ND, 1 nM) in COLO 205 c
## Abstract Small cell carcinoma of the prostate (SCCP), although relatively rare, is the most aggressive variant of prostate cancer, currently with no successful treatment. It was therefore tempting to evaluate the response of this violent malignancy and its bone lesions to PdβBacteriopheophorbide